BEP protocol: Clinical Trials

4 trials of BEP protocol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 2 Not applicable, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Recruiting 1
Phase 31Completed 1
Phase 41Completed 1

Follow BEP protocol: new trials by email Literature Review of BEP protocol trials Research Report on BEP protocol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors
BEP Protocol, Dose-dense regimen, Early tumor resection or HD-CT - Non-Seminomatous Germ Cell Tumor
Not applicableRecruitingGustave Roussy, Cancer Campus, Grand Paris1502023-05-052025-05-08
Effect of a Fortified Balanced Energy-Protein Supplement on Birth Outcome and Child Growth in Houndé District, Burkina Faso.
Fortified balanced energy-protein (BEP) supplement, Fe and folic acid supplement - Small for Gestational Age at Delivery, Low Birth Weight
Phase 4CompletedUniversity Ghent17882019-10-302022-03-22
Treatment of In-Stent Restenosis 2 Study
sirolimus-eluting balloon (SEB) MagicTouch, paclitaxel-eluting balloon (PEB) Sequent Please - Coronary Restenosis
Phase 3CompletedUniversity Hospital Ostrava2002018-10-012022-12-07
Patient Education Bundle vs. Nurses Feedback and Coaching to Prevent Missed Doses of VTE Prophylaxis
Patient education bundle (PEB),, Nurse feedback and coaching (NFC) - Venous Thrombosis (Disorder)
Not applicableCompletedJohns Hopkins University96572018-01-012023-03-02

Conditions studied

Coronary Restenosis (1)  ·  Infant Nutrition Disorders (1)  ·  Nonseminomatous germ cell tumor (1)  ·  Premature Birth (1)  ·  Venous Thromboembolism (1)  ·  Venous Thrombosis (1)

Sponsors

Gustave Roussy, Cancer Campus, Grand Paris (1)  ·  Johns Hopkins University (1)  ·  University Ghent (1)  ·  University Hospital Ostrava (1)

Countries

Burkina Faso (1)  ·  Czechia (1)  ·  France (1)  ·  United States (1)

Top investigators

Brenda PH de Kok, MSc. (1)  ·  Carl Lachat, Prof. dr. (1)  ·  Elliott R Haut, MD. PhD (1)  ·  Katrien W Vanslambrouck, MD (1)  ·  Laeticia Celine Toe, MD MSc. (1)  ·  Lieven F Huybregts, PhD (1)  ·  Patrick Kolsteren, Prof. dr. (1)  ·  Sheila Isanaka, Asst. Prof. (1)

Results publications

PMID 33762226, PMID 34494113, PMID 35524695, PMID 35560315, PMID 35906874, PMID 36047732, PMID 36745684, PMID 37486952, PMID 40171676

NIH funding

2023 (1)